Cleared Traditional

NBM-200MP PULSE OXIMETRY DEVICE (K091564) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K091564 · Orsense, Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2010
Decision
295d
Days
Class 2
Risk

K091564 is an FDA 510(k) clearance for the NBM-200MP PULSE OXIMETRY DEVICE. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Orsense, Ltd. (Kfar Saba, IL). The FDA issued a Cleared decision on March 19, 2010 after a review of 295 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Orsense, Ltd. devices

Submission Details

510(k) Number K091564 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 2009
Decision Date March 19, 2010
Days to Decision 295 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
155d slower than avg
Panel avg: 140d · This submission: 295d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 200
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K091564.
VITAL SIGNS MONITOR
K102835 · Edan Instruments, Inc. · Dec 2010
V-TRUST HANDHELD PULSE OXIMETER MODEL: TD-8201
K101012 · Taidoc Technology Corporation · Dec 2010
VITAL SIGNS MONITOR MODEL M3B
K101539 · Edan Instruments, Inc. · Nov 2010
H100B PULSE OXIMETER
K092727 · Edan Instruments, Inc. · Dec 2009
VITAL SIGNS MONITOR
K083821 · Edan Instruments, Inc. · May 2009
N-600X WITH SPD, OXIMAX N-600X
K083325 · Covidien · Mar 2009